Cardiac dysfunction associated with a nucleotide polymerase inhibitor for treatment of hepatitis C-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cardiac dysfunction associated with a nucleotide polymerase inhibitor for treatment of hepatitis C

Published:2015-05-26 Issue:2 Volume:62 Page:409-416
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Ahmad Tariq¹,Yin Philip²,Saffitz Jeffrey³,Pockros Paul J.⁴,Lalezari Jacob⁵,Shiffman Mitchell⁶,Freilich Bradley⁷,Zamparo Joann²,Brown Kyle²,Dimitrova Dessislava⁸,Kumar Monica⁸,Manion Doug⁸,Heath-Chiozzi Margo²,Wolf Robert⁹,Hughes Eric⁹,Muir Andrew J.¹,Hernandez Adrian F.¹

Affiliation:

1. Duke Clinical Research Institute; Durham NC

2. Bristol-Myers Squibb; Wallingford CT

3. Harvard Medical School, Beth Israel Deaconess Medical Center; Boston MA

4. Scripps Clinic; La Jolla CA

5. Quest Clinical Research; San Francisco CA

6. Liver Institute of Virginia, Bon Secours Health System; Newport News VA

7. Kansas City Gastroenterology & Hepatology Physicians Group; Kansas City MO

8. Bristol-Myers Squibb; Hopewell NJ

9. Bristol-Myers Squibb; Lawrenceville NJ

Funder

Bristol Myers Squibb

Publisher

Wiley

Subject

Hepatology

Reference18 articles.

1. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence;Mohd Hanafiah;Hepatology,2013

2. American Association for the Study of Liver Diseases. Diagnosis, management, and treatment of hepatitis C: an update;Ghany;Hepatology,2009

3. Current and future therapies for hepatitis C virus infection;Liang;N Engl J Med,2013

4. The race for interferon-free HCV therapies: a snapshot by the spring of 2012;De Clercq;Rev Med Virol,2012

5. Expediting drug development-the FDA's new “breakthrough therapy” designation;Sherman;N Engl J Med,2013

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Direct-Acting Antivirals and the Risk of Arrhythmias and Conduction Disorders in Patients with Chronic Hepatitis C: A French Nationwide Cohort Study;Drugs;2023-07-12

2. Evaluation of chronic drug-induced electrophysiological and cytotoxic effects using human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs);Frontiers in Pharmacology;2023-07-10

3. Cardiovascular Risk Assessment after Sofosbuvir and Daclatasvir Regimen for Chronic Hepatitis C Virus Infection;Journal of the Pakistan Medical Association;2023-05-25

4. Evaluation of left ventricular function after sofosbuvir and daclatasvir regimen for chronic hepatitis C;Journal of the Pakistan Medical Association;2023-05-25

5. Safety considerations in the management of hepatitis C and HIV co-infection;Expert Opinion on Drug Safety;2023-04-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3